175 related articles for article (PubMed ID: 30981401)
1. APOL1 risk genotype in Europe: Data in patients with focal segmental glomerulosclerosis and after renal transplantation.
Servais A; Gribouval O; Gaillard F; Antignac C
Nephrol Ther; 2019 Apr; 15 Suppl 1():S85-S89. PubMed ID: 30981401
[TBL] [Abstract][Full Text] [Related]
2. APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestries.
Gribouval O; Boyer O; Knebelmann B; Karras A; Dantal J; Fourrage C; Alibeu O; Hogan J; Dossier C; Tête MJ; Antignac C; Servais A
Nephrol Dial Transplant; 2019 Nov; 34(11):1885-1893. PubMed ID: 29992269
[TBL] [Abstract][Full Text] [Related]
3. Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 Cases.
Chang JH; Husain SA; Santoriello D; Stokes MB; Miles CD; Foster KW; Li Y; Dale LA; Crew RJ; Cohen DJ; Kiryluk K; Gharavi AG; Mohan S
Am J Kidney Dis; 2019 Jan; 73(1):134-139. PubMed ID: 30054024
[TBL] [Abstract][Full Text] [Related]
4. APOL1 in an ethnically diverse pediatric population with nephrotic syndrome: implications in focal segmental glomerulosclerosis and other diagnoses.
Watanabe A; Guaragna MS; Belangero VMS; Casimiro FMS; Pesquero JB; de Santis Feltran L; Palma LMP; Varela P; de Menezes Neves PDM; Lerario AM; de Souza ML; de Mello MP; de Brito Lutaif ACG; Ferrari CR; Sampson MG; Onuchic LF; Nogueira PCK
Pediatr Nephrol; 2021 Aug; 36(8):2327-2336. PubMed ID: 33585978
[TBL] [Abstract][Full Text] [Related]
5. The APOL1 gene and allograft survival after kidney transplantation.
Reeves-Daniel AM; DePalma JA; Bleyer AJ; Rocco MV; Murea M; Adams PL; Langefeld CD; Bowden DW; Hicks PJ; Stratta RJ; Lin JJ; Kiger DF; Gautreaux MD; Divers J; Freedman BI
Am J Transplant; 2011 May; 11(5):1025-30. PubMed ID: 21486385
[TBL] [Abstract][Full Text] [Related]
6. Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
Santoriello D; Husain SA; De Serres SA; Bomback AS; Crew RJ; Vasilescu ER; Serban G; Campenot ES; Kiryluk K; Mohan S; Hawkins GA; Hicks PJ; Cohen DJ; Radhakrishnan J; Stokes MB; Markowitz GS; Freedman BI; D'Agati VD; Batal I
Kidney Int; 2018 Dec; 94(6):1189-1198. PubMed ID: 30287079
[TBL] [Abstract][Full Text] [Related]
7. APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts.
Ng DK; Robertson CC; Woroniecki RP; Limou S; Gillies CE; Reidy KJ; Winkler CA; Hingorani S; Gibson KL; Hjorten R; Sethna CB; Kopp JB; Moxey-Mims M; Furth SL; Warady BA; Kretzler M; Sedor JR; Kaskel FJ; Sampson MG
Nephrol Dial Transplant; 2017 Jun; 32(6):983-990. PubMed ID: 27190333
[TBL] [Abstract][Full Text] [Related]
8. An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.
Robertson CC; Gillies CE; Putler RKB; Ng D; Reidy KJ; Crawford B; Sampson MG
Nephrol Dial Transplant; 2017 Dec; 32(12):2051-2058. PubMed ID: 27638911
[TBL] [Abstract][Full Text] [Related]
9. APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis.
Zee J; McNulty MT; Hodgin JB; Zhdanova O; Hingorani S; Jefferson JA; Gibson KL; Trachtman H; Fornoni A; Dell KM; Reich HN; Bagnasco S; Greenbaum LA; Lafayette RA; Gipson DS; Brown E; Kretzler M; Appel G; Sambandam KK; Tuttle KR; Chen D; Atkinson MA; Hogan MC; Kaskel FJ; Meyers KE; O'Toole J; Srivastava T; Sethna CB; Hladunewich MA; Lin JJ; Nast CC; Derebail VK; Patel J; Vento S; Holzman LB; Athavale AM; Adler SG; Lemley KV; Lieske JC; Hogan JJ; Gadegbeku CA; Fervenza FC; Wang CS; Matar RB; Singer P; Kopp JB; Barisoni L; Sampson MG
Pediatr Nephrol; 2021 Sep; 36(9):2747-2757. PubMed ID: 33646395
[TBL] [Abstract][Full Text] [Related]
10. Early recurrence of focal segmental glomerulosclerosis in a kidney transplant recipient with
Acharya R; Upadhyay K
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37258049
[No Abstract] [Full Text] [Related]
11. Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial.
Kopp JB; Winkler CA; Zhao X; Radeva MK; Gassman JJ; D'Agati VD; Nast CC; Wei C; Reiser J; Guay-Woodford LM; Pollak MR; Hildebrandt F; Moxey-Mims M; Gipson DS; Trachtman H; Friedman AL; Kaskel FJ;
J Am Soc Nephrol; 2015 Jun; 26(6):1443-8. PubMed ID: 25573908
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein L1 and kidney transplantation.
Tedla FM; Yap E
Curr Opin Organ Transplant; 2019 Feb; 24(1):97-102. PubMed ID: 30507707
[TBL] [Abstract][Full Text] [Related]
13. APOL1 Polymorphisms in a Deceased Donor and Early Presentation of Collapsing Glomerulopathy and Focal Segmental Glomerulosclerosis in Two Recipients.
Shah PB; Cooper JE; Lucia MS; Boils C; Larsen CP; Wiseman AC
Am J Transplant; 2016 Jun; 16(6):1923-1927. PubMed ID: 26849829
[TBL] [Abstract][Full Text] [Related]
14. APOL1 polymorphisms and development of CKD in an identical twin donor and recipient pair.
Kofman T; Audard V; Narjoz C; Gribouval O; Matignon M; Leibler C; Desvaux D; Lang P; Grimbert P
Am J Kidney Dis; 2014 May; 63(5):816-9. PubMed ID: 24518129
[TBL] [Abstract][Full Text] [Related]
15. APOL1-Associated End-Stage Renal Disease in a Living Kidney Transplant Donor.
Zwang NA; Shetty A; Sustento-Reodica N; Gordon EJ; Leventhal J; Gallon L; Friedewald JJ
Am J Transplant; 2016 Dec; 16(12):3568-3572. PubMed ID: 27588375
[TBL] [Abstract][Full Text] [Related]
16. Most ApoL1 Is Secreted by the Liver.
Shukha K; Mueller JL; Chung RT; Curry MP; Friedman DJ; Pollak MR; Berg AH
J Am Soc Nephrol; 2017 Apr; 28(4):1079-1083. PubMed ID: 27932478
[TBL] [Abstract][Full Text] [Related]
17. Transplantation With APOL1 Risk Variant Kidney May Be Associated With Lifetime Risk for Recurrence of Focal Segmental Glomerulosclerosis: A Case Report and Review of Literature.
Mirza A; Kowalewska J; McCune T
Transplant Proc; 2019 Nov; 51(9):3077-3079. PubMed ID: 31324484
[TBL] [Abstract][Full Text] [Related]
18. Malaria, Collapsing Glomerulopathy, and Focal and Segmental Glomerulosclerosis.
Amoura A; Moktefi A; Halfon M; Karras A; Rafat C; Gibier JB; Gleeson PJ; Servais A; Argy N; Maillé P; Belenfant X; Gueutin V; Delpierre A; Tricot L; El Karoui K; Jourde-Chiche N; Houze S; Sahali D; Audard V
Clin J Am Soc Nephrol; 2020 Jul; 15(7):964-972. PubMed ID: 32444394
[TBL] [Abstract][Full Text] [Related]
19. De Novo Focal and Segmental Glomerulosclerosis After COVID-19 in a Patient With a Transplanted Kidney From a Donor With a High-risk APOL1 Variant.
Oniszczuk J; Moktefi A; Mausoleo A; Pallet N; Malard-Castagnet S; Fourati S; El Karoui K; Sahali D; Stehlé T; Boueilh A; Verpont MC; Matignon M; Buob D; Grimbert P; Audard V
Transplantation; 2021 Jan; 105(1):206-211. PubMed ID: 32852403
[TBL] [Abstract][Full Text] [Related]
20. Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes.
Dorr CR; Freedman BI; Hicks PJ; Brown WM; Russell GB; Julian BA; Pastan SO; Gautreaux MD; Muthusamy A; Chinnakotla S; Hauptfeld V; Bray RA; Kirk AD; Divers J; Israni AK
PLoS One; 2016; 11(4):e0152775. PubMed ID: 27054572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
